Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night. | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on ...
In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), ...
GSK and Pfizer ... s consumer health business, according to Bloomberg. The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care.
While Congress twiddles its thumbs, pharmaceutical giants like Lilly, Pfizer, and Nova Nordisk are revolutionizing healthcare by slashing prices and tossing medical responsibility around like a hot ...
GlaxoSmithKline is understood to be the sole bidder for Pfizer’s $15-20bn consumer health unit after Reckitt Benckiser pulled out. Reckitt’s shares jumped after it published a short statement ...
PfizerForAll aims to help improve health care by offering telehealth services, prescription services, vaccination scheduling, and savings programs. Pfizer launched a direct-to-consumer service ...
On Tuesday, Pfizer ... our healthcare system is time-consuming. It's complicated. It's overwhelming. And the last thing that anybody needs when they're trying to get the care that they need ...
BURLINGAME, CA, UNITED STATES, September 18, 2024 /EINPresswire / -- Latest Report, titled“U.S. Nasal Spray Market” Trends, Share, Size, Growth, Opportunity and ...
On Tuesday, Pfizer (PFE) said it will enter the direct-to-consumer business ... is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital ...
Biopharmaceutical company Pfizer is starting to serve consumers directly through its new telehealth platform called PfizerForAll, the company announced Tuesday. Pfizer declared that the platform ...
Aug 27 (Reuters) - Pfizer Inc (PFE.N), opens new tab is launching a new website to promote and improve access to its health care offerings ... to enhance that consumer experience, but we're ...